Diastrophic Dysplasia Treatment & Management
- Author: Shital Parikh, MD; Chief Editor: Harris Gellman, MD more...
Medical Therapy
Nutritional counseling may be appropriate. As a result of progressive contractures, spine deformities, and joint involvement, patients are relatively inactive. Many patients have difficulty in ambulation, and some are wheelchair bound. Obesity can be an issue in patients with decreased activity levels, and dietary therapy should be initiated early in life.
Surgical Therapy
Various operations may be performed for patients with diastrophic dysplasia[15, 32, 33] :
- Palatoplasty may be required during the initial years of life.
- A lateral radiograph should be obtained during the first 2 years of life, and if cervical kyphosis is present, the patient should be monitored clinically and radiographically every 6 months. If the kyphosis progresses with no neurologic deficit, a Milwaukee brace may be used full time. If the curve progresses despite bracing or if neurologic deficit occurs, posterior fusion should be performed. Care should be taken during exposure because of bifid lamina, and instrumentation usually is not technically possible. Immobilization with a halo and vest is required for 2-4 months. If anterior compression is evident on MRI, corpectomy and strut grafts may be indicated.
- The results of brace treatment for scoliosis in diastrophic dysplasia have been poor, and bracing is not recommended for progressive curves or curves larger than 45°. Early surgical intervention has been proposed. Posterior fusion is the mainstay of treatment. For young patients or those with associated kyphosis of more than 50°, anterior fusion may be added.
- Hip flexion contractures and knee flexion contractures should be assessed together. If they are significant (>40°), release may be considered if the potential for gaining motion is good. If epiphyseal flattening is present, releases should be avoided because recurrences are common. Acetabular augmentation or femoral osteotomy can be performed for the treatment of hip dysplasia. Supracondylar osteotomies may be performed for knee flexion contractures, but these frequently recur. The hip contractures should be corrected first, as these may influence the recurrence of the knee deformity. Patellar subluxation may be corrected to help improve extensor power. Degenerative changes in the hip may require hip joint arthroplasty.
- The feet are rigid, and cast treatment is usually futile. A plantigrade foot is the goal of treatment. The recurrence rate for deformity of the foot treated with tenotomy, lengthening of calcaneal tendon, or posteromedial release is more than 80%. Thus, surgical release should be as extensive as needed to correct the deformity; this goal may require release of inferior tibiofibular ligament to bring the dome of talus into the mortise. Salvage procedures include talectomy, talocalcaneal decancellation, and arthrodesis in the older child.
Follow-up
- Patients may benefit from the information on the Web site for diastrophic dysplasia, Diastrophic Help.
- An important resource for individuals with short stature is the Little People of America (LPA) Organization. The LPA is a national organization that addresses the social, physical, and medical needs of its constituency. It holds annual regional and national conventions. Philosophically, this organization emphasizes the positive aspects of their members' abilities and lives rather than presenting short stature as a disability.
- The Dwarf Athletic Association of America (DAAA) is a member of the US Olympic Committee that promotes athletic participation for individuals with short stature.
Complications
Morbidity occurs due to the following associated conditions:
- Cleft palate
- Respiratory insufficiency due to laryngotracheobronchomalacia
- Progressive deformities and contractures of joints
- Progressive hip dysplasia and dislocation
- Severe foot deformities
- Severe hand deformities
- Progressive spinal deformities (scoliosis, kyphosis, lordosis)
- Cervical kyphosis with neurologic involvement
- Early degenerative changes in joints
Outcome and Prognosis
Patients have a minimally (5%) increased rate of perinatal mortality due to cervical myelopathy or respiratory problems such as aspiration pneumonia and laryngotracheomalacia. Patients with severe spinal deformities are also predisposed to the development of respiratory problems. A lethal form of diastrophic dysplasia has been described that can cause death soon after birth due to cardiorespiratory insufficiency. Overall, life expectancy is not reduced, and patients are able to lead productive lives at work and with their families.
Future and Controversies
When one discusses height in patients with short stature, the term smaller than average may be substituted for the term dwarf.
The term pseudodiastrophic dwarfism is used for a disorder that clinically, radiologically, and histologically differs from true diastrophic dysplasia, and it should not be used inadvertently.
Lamy M, Maroteaux P. Le nanisme diastrophique. Presse Med. 1960;68:1977-80.
International nomenclature and classification of the osteochondrodysplasias (1997). International Working Group on Constitutional Diseases of Bone. Am J Med Genet. Oct 12 1998;79(5):376-82. [Medline].
International nomenclature of constitutional diseases of bone. Revision, May, 1977. Ann Radiol (Paris). Mar-Apr 1978;21(2-3):253-8. [Medline].
Barbosa M, Sousa AB, Medeira A, Lourenço T, Saraiva J, Pinto-Basto J, et al. Clinical and molecular characterization of Diastrophic Dysplasia in the Portuguese population. Clin Genet. Dec 2011;80(6):550-7. [Medline].
Hastbacka J, Kerrebrock A, Mokkala K. Identification of the Finnish founder mutation for diastrophic dysplasia (DTD). Eur J Hum Genet. Sep 1999;7(6):664-70. [Medline].
Maeda K, Miyamoto Y, Sawai H, Karniski LP, Nakashima E, Nishimura G. A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia. Am J Med Genet A. Jun 1 2006;140(11):1143-7. [Medline].
Miyake A, Nishimura G, Futami T, Ohashi H, Chiba K, Toyama Y, et al. A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia. J Hum Genet. 2008;53(8):764-8. [Medline].
Dwyer E, Hyland J, Modaff P, Pauli RM. Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family. Am J Med Genet A. Dec 2010;152A(12):3043-50. [Medline].
Cushing SL, Swanson RL, Sie KC. Prevention of auricular deformity in children with diastrophic dysplasia. Int J Pediatr Otorhinolaryngol. Mar 15 2011;[Medline].
Qureshi F, Jacques SM, Johnson SF. Histopathology of fetal diastrophic dysplasia. Am J Med Genet. Apr 10 1995;56(3):300-3. [Medline].
Remes V, Poussa M, Lönnqvist T, Puusa A, Tervahartiala P, Helenius I. Walking ability in patients with diastrophic dysplasia: a clinical, electroneurophysiological, treadmill, and MRI analysis. J Pediatr Orthop. Sep-Oct 2004;24(5):546-51. [Medline].
Karlstedt E, Kovero O, Kaitila I. Transverse facial morphology in patients with diastrophic dysplasia. J Craniofac Genet Dev Biol. Oct-Dec 1997;17(4):178-83. [Medline].
Karlstedt E, Isotalo E, Haapanen ML. Correlation between speech outcome and cephalometric dimensions in patients with diastrophic dysplasia. J Craniofac Genet Dev Biol. Jan-Mar 1998;18(1):38-43. [Medline].
Kash IJ, Sane SM, Samaha FJ. Cervical cord compression in diastrophic dwarfism. J Pediatr. Jun 1974;84(6):862-4. [Medline].
Matsuyama Y, Winter RB, Lonstein JE. The spine in diastrophic dysplasia. The surgical arthrodesis of thoracic and lumbar deformities in 21 patients. Spine. Nov 15 1999;24(22):2325-31. [Medline].
Remes V, Tervahartiala P, Poussa M. Thoracic and lumbar spine in diastrophic dysplasia: a clinical and magnetic resonance imaging analysis. Spine. Jan 15 2001;26(2):187-95. [Medline].
Remes V, Marttinen E, Poussa M. Cervical kyphosis in diastrophic dysplasia. Spine. Oct 1 1999;24(19):1990-5. [Medline].
Remes V, Tervahartiala P, Poussa M. Cervical spine in diastrophic dysplasia: an MRI analysis. J Pediatr Orthop. Jan-Feb 2000;20(1):48-53. [Medline].
Remes V, Poussa M, Peltonen J. Scoliosis in patients with diastrophic dysplasia: a new classification. Spine. Aug 1 2001;26(15):1689-97. [Medline].
Vaara P, Peltonen J, Poussa M. Development of the hip in diastrophic dysplasia. J Bone Joint Surg Br. Mar 1998;80(2):315-20. [Medline].
Peltonen J, Vaara P, Marttinen E. The knee joint in diastrophic dysplasia. A clinical and radiological study. J Bone Joint Surg Br. Jul 1999;81(4):625-31. [Medline].
Ryoppy S, Poussa M, Merikanto J. Foot deformities in diastrophic dysplasia. An analysis of 102 patients. J Bone Joint Surg Br. May 1992;74(3):441-4. [Medline].
Weiner DS, Jonah D, Kopits S. The 3-dimensional configuration of the typical foot and ankle in diastrophic dysplasia. J Pediatr Orthop. Jan-Feb 2008;28(1):60-7. [Medline].
Remes VM, Helenius IJ, Marttinen EJ. Manubrium sterni in patients with diastrophic dysplasia--radiological analysis of 50 patients. Pediatr Radiol. Aug 2001;31(8):555-8. [Medline].
Remes V, Tervahartiala P, Helenius I. Magnetic resonance imaging analysis of hip joint development in patients with diastrophic dysplasia. J Pediatr Orthop. Mar-Apr 2002;22(2):212-6. [Medline].
Miller E, Blaser S, Miller S, Keating S, Thompson M, Unger S, et al. Fetal MR imaging of atelosteogenesis type II (AO-II). Pediatr Radiol. Aug 21 2008;[Medline].
Vaara P, Marttinen E, Peltonen J. Ultrasonography of the patellofemoral joint in diastrophic dysplasia. J Pediatr Orthop. Jul-Aug 1997;17(4):512-5. [Medline].
Canto MJ, Buixeda M, Palau J, Ojeda F. Early ultrasonographic diagnosis of diastrophic dysplasia at 12 weeks of gestation in a fetus without previous family history. Prenat Diagn. Oct 2007;27(10):976-8. [Medline].
Canto MJ, Buixeda M, Palau J, Ojeda F. Early ultrasonographic diagnosis of diastrophic dysplasia at 12 weeks of gestation in a fetus without previous family history. Prenat Diagn. Oct 2007;27(10):976-8. [Medline].
Basbug M, Ozgun MT, Serin IS, Akgun H, Dundar M, Kurtoglu S. OC236: Prenatal diagnosis of skeletal dysplasias: 12-year single-center experience. Ultrasound Obstet Gynecol. Oct 2007;30(4):439. [Medline].
Sepulveda W, Sepulveda-Swatson E, Sanchez J. Diastrophic dysplasia: prenatal three-dimensional ultrasound findings. Ultrasound Obstet Gynecol. Mar 2004;23(3):312-4. [Medline].
Hunter AG. Perceptions of the outcome of orthopedic surgery in patients with chondrodysplasias. Clin Genet. Dec 1999;56(6):434-40. [Medline].
Helenius I, Remes V, Tallroth K, Peltonen J, Poussa M, Paavilainen T. Total hip arthroplasty in diastrophic dysplasia. J Bone Joint Surg Am. Mar 2003;85-A(3):441-7. [Medline].
Haila S, Hastbacka J, Bohling T. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types. J Histochem Cytochem. Aug 2001;49(8):973-82. [Medline].
Horton WA, Hall JG, Scott CI. Growth curves for height for diastrophic dysplasia, spondyloepiphyseal dysplasia congenita, and pseudoachondroplasia. Am J Dis Child. Apr 1982;136(4):316-9. [Medline].
Horton WA, Rimoin DL, Lachman RS. The phenotypic variability of diastrophic dysplasia. J Pediatr. Oct 1978;93(4):609-13. [Medline].
Makitie O, Kaitila I. Growth in diastrophic dysplasia. J Pediatr. Apr 1997;130(4):641-6. [Medline].
Richards BS. Atlanto-axial instability in diastrophic dysplasia. A case report. J Bone Joint Surg Am. Apr 1991;73(4):614-6. [Medline].
Rimoin DL. The chondrodystrophies. Adv Hum Genet. 1975;5:1-118. [Medline].
Walker BA, Scott CI, Hall JG. Diastrophic dwarfism. Medicine (Baltimore). Jan 1972;51(1):41-59. [Medline].

